13F-HR filed by SECTORAL ASSET MANAGEMENT INC
SECTORAL ASSET MANAGEMENT INC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 104 holding rows worth $232,224,456.
- Accession
- 0001104659-24-022582
- Filer
- CIK 1274413
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 104 entries on the cover page, a total value of $232,224,456 stated on the cover page (in dollars after the unit check, H1), rows summing to $232,224,456 with VALUE read as dollars as filed, 13F file number 028-10653. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 26,565 | $15,485,270 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 18,925 | $9,963,445 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 79,500 | $8,667,090 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 53,850 | $8,440,449 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 28,685 | $8,261,854 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 68,998 | $7,594,610 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 46,300 | $7,175,111 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 189,400 | $5,452,826 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 91,476 | $5,288,228 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 605,606 | $5,208,212 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 50,070 | $4,827,749 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 9,015 | $4,785,072 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 22,640 | $4,333,522 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 15,827 | $4,095,553 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 16,600 | $3,840,908 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 10,027 | $3,814,572 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 8,225 | $3,765,487 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 9,219 | $3,751,119 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 29,400 | $3,648,246 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 327,801 | $3,586,143 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 14,975 | $3,464,317 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 3,835 | $3,368,242 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 40,905 | $3,313,714 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 40,051 | $3,299,401 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 650,911 | $2,955,136 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 10,203 | $2,888,163 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 142,510 | $2,887,253 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 12,950 | $2,809,891 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 66,000 | $2,716,560 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 623,684 | $2,675,604 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 305,412 | $2,574,623 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 274,623 | $2,468,861 | dollars as filed | |
| GOODRX HLDGS INC | 38246G108 | COM CL A | 364,000 | $2,438,800 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 325,549 | $2,428,596 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 220,056 | $2,409,613 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 156,769 | $2,224,552 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 64,000 | $2,156,160 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 685,985 | $2,126,554 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 90,310 | $2,079,839 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 21,541 | $2,077,199 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 752,381 | $2,054,000 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 32,800 | $2,041,144 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 92,060 | $1,989,417 | dollars as filed | |
| CONMED CORP COM | 207410101 | Stock | 18,100 | $1,982,131 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 292,592 | $1,980,848 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 354,641 | $1,943,433 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 170,800 | $1,921,500 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 124,151 | $1,909,442 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 81,160 | $1,875,608 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 97,435 | $1,861,009 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 20,439 | $1,824,998 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 30,005 | $1,812,002 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 26,130 | $1,759,856 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 706,062 | $1,736,913 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 46,777 | $1,699,876 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 21,900 | $1,669,875 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 203,327 | $1,655,082 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 198,800 | $1,616,244 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 16,100 | $1,601,145 | dollars as filed | |
| TURNSTONE BIOLOGICS CORP | 90042W100 | COM | 517,648 | $1,317,414 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 84,055 | $1,237,290 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 441,829 | $1,157,592 | dollars as filed | |
| EFFECTOR THERAPEUTICS INC | 28202V108 | COM | 2,382,644 | $1,113,648 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 6,600 | $918,984 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 2,235 | $707,400 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 14,090 | $700,696 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 3,752 | $676,711 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 10,105 | $634,493 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,815 | $618,990 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 4,445 | $585,673 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 7,013 | $585,515 | dollars as filed | |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 20,570 | $577,811 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 4,441 | $559,344 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 57,297 | $550,624 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 7,420 | $531,420 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 17,896 | $530,616 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 12,955 | $522,993 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 8,050 | $505,540 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 4,094 | $503,562 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 15,060 | $471,529 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 13,811 | $428,003 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 15,330 | $425,254 | dollars as filed | |
| MEDPACE HLDGS INC COM | 58506Q109 | Stock | 1,371 | $420,253 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 36,457 | $409,412 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 13,710 | $393,203 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 3,725 | $393,137 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 6,474 | $380,348 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 12,280 | $368,032 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 13,990 | $335,620 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 6,480 | $327,823 | dollars as filed | |
| DR REDDYS LABS LTD ADR | 256135203 | ADR | 4,500 | $313,110 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 5,220 | $312,469 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 9,300 | $283,557 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,201 | $277,887 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 12,881 | $276,426 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 19,230 | $269,797 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 8,182 | $250,369 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 2,470 | $227,833 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 6,030 | $222,869 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 3,000 | $180,510 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 3,400 | $138,584 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 7,355 | $111,428 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 4,000 | $109,320 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 30,000 | $78,300 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-022582 | this filing | 2024-02-14 | acceptance time not in the bulk data set |